Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ascites × Zoledronic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Osteosarcoma 3 Neuroblastoma 3 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1 Stomach Neoplasms 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Rhabdoid Tumor 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroectodermal Tumors, Primitive 1 Nerve Sheath Neoplasms 1 Myoepithelioma 1 Myelodysplastic Syndromes 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Hodgkin Disease 1 Giant Cell Tumor of Bone 1 Desmoplastic Small Round Cell Tumor 1 Chordoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Ascites 1 Adenocarcinoma 1

Interventions

contrast agent BR1 1 Zoledronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06759064 2025-11-19

IPIZA

Qilu Hospital of Shandong University

Phase 1/2 Recruiting

Gastrointestinal

Adenocarcinoma, Ascites, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡